| Hans-Günter Meyer-Thompson | Hepatitiden
Experiences with interferon-free hepatitis C therapies: addressing barriers to adherence and optimizing treatment outcomes.
Experiences with interferon-free hepatitis C therapies: addressing barriers to adherence and optimizing treatment outcomes.
Skolnik AA, Noska A, Yakovchenko V, Tsai J, Jones N, Gifford AL, McInnes DK.
BMC Health Serv Res. 2019 Feb 1;19(1):91. doi: 10.1186/s12913-019-3904-9.